Merck Aktie
WKN DE: A2DUS5 / ISIN: US5893392093
25.04.2025 03:26:37
|
Merck KGaA In Late-Stage Acquisition Talks With SpringWorks Therapeutics
(RTTNews) - Responding to press reports, Merck KGaA (MKGAY.PK) confirmed late-stage discussions with SpringWorks Therapeutics Inc. (SWTX) on a potential acquisition.
Merck KGaA noted that the companies are in discussion on the basis of a price of around US$47 per share. No final decision has been taken and no legally binding agreement has been entered into.
SWTX closed Thursday's regular trading at $44.93 up $3.72 or 9.03%. But in the after-hours trading, the stock dipped by $0.08 or 0.18%.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu SpringWorks Therapeutics Inc Registered Shsmehr Nachrichten
Analysen zu SpringWorks Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Merck KGaA Sponsored American Deposit Receipt | 23,40 | 0,86% |
|